Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationCombined Modality TherapyTransplantation, HomologousMelphalanTransplantation ConditioningStem CellsTreatment OutcomeBone Marrow TransplantationRemission InductionBone MarrowRecurrenceSalvage TherapyAmyloidosisBone Marrow CellsDisease-Free SurvivalBoronic AcidsHodgkin DiseaseThalidomidePyrazinesEtoposideCyclophosphamideHematopoietic Stem CellsLymphoma, Non-HodgkinBone Marrow PurgingHematopoietic Stem Cell MobilizationGraft vs Host DiseaseMyeloablative AgonistsCytarabineCarmustineSurvival RateHematologic NeoplasmsThiotepaVincristineWhole-Body IrradiationSurvival AnalysisRetrospective StudiesGraft SurvivalLymphoma, Mantle-CellBusulfanAntigens, CD34DexamethasonePrognosisDoxorubicinLymphoma, FollicularAntibodies, Monoclonal, Murine-DerivedFollow-Up StudiesTime FactorsLymphoma, T-Cell, PeripheralMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorAntineoplastic Agents, AlkylatingAutograftsIfosfamideAntineoplastic AgentsLymphomaTissue DonorsLeukapheresisEmbryonic Stem CellsBone and BonesPrednisoneInduction ChemotherapyPodophyllotoxinLeukemia, Myeloid, AcuteAdult Stem CellsTransplantation ChimeraCell DifferentiationNeoplasm, ResidualLymphoma, Large B-Cell, DiffuseMaintenance ChemotherapyImmunosuppressive AgentsKidney TransplantationMyelodysplastic SyndromesHistocompatibility TestingTransplantationHematopoiesisCord Blood Stem Cell TransplantationLymphoma, B-CellMesenchymal Stromal CellsLiver TransplantationProspective StudiesMitoxantroneCell TransplantationFatal OutcomeEnteropathy-Associated T-Cell LymphomaPluripotent Stem CellsAntibodies, MonoclonalHistocompatibilityLeukemiaLeukemia, MyeloidIdarubicinLeukemia, Plasma CellCells, CulturedInfusions, SpinalNeoplasms, Second PrimaryBlood Component Removal